IllnessCerebrotendinous xanthomatosis, CTX
Summary
Curated single gene sequence analysis according to clinical suspicion cerebrotendinous Xanthomatosis
- (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
CYP27A1 | 1596 | NM_000784.4 | AR |
Informations about the disease
Cerebrotendinous Xanthomatosis manifests as fat storage disease in childhood with cataracts, in adolescents with tendon xanthomas and in adults with dementia and psychiatric abnormalities as well as progressive neurological dysfunction (pyramidal tract and cerebellar signs, dystonia, atypical parkinsonism, peripheral neuropathy, seizures). CTX diagnosis is established biochemically in blood and urine via cholestanol detection. CTX follows the autosomal recessive inheritance pattern. Together with extensive deletion/duplication analysis, DNA sequencing is used to molecularly clarify virtually all clinically definite cases, confirming the clinical diagnosis.
Reference: https://www.ncbi.nlm.nih.gov/books/NBK1409/
- Alias: Sterol 27-hydroxylase deficiency (CYP27A1)
- Alias: Zerebrotendinöse Xanthomatose (CYP27A1)
- CTX (CYP27A1)
- Cerebrotendinous xanthomatosis (CYP27A1)
- AR
Bioinformatics and clinical interpretation
No text defined